Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iScience Surgical was a medical technology company specializing in the development of micro-interventional surgical devices for the treatment of glaucoma. The company's flagship product, the iTrack surgical system, featured a microcatheter designed for canaloplasty, a procedure that restores the eye's natural drainage system. By providing high-resolution imaging and precise delivery of visco-elastic fluid, iScience Surgical's technology aimed to offer a minimally invasive alternative to traditional glaucoma surgeries. The company was acquired by Ellex Medical Lasers in 2014, and its technology now forms a core part of Nova Eye Medical's glaucoma portfolio. Its innovations significantly advanced the field of micro-invasive glaucoma surgery (MIGS) by focusing on the restoration of physiological outflow pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iScience Surgical.